Weichselbaum RR - Search Results

1

p52 signaling promotes cellular senescence.

Bernal GM, Wu L, Voce DJ, Weichselbaum RR, Yamini B. Bernal GM, et al. Among authors: weichselbaum rr. Cell Biosci. 2022 Apr 4;12(1):43. doi: 10.1186/s13578-022-00779-6. Cell Biosci. 2022. PMID: 35379326 Free PMC article.

2

Transcriptional targeting of adenovirally delivered tumor necrosis factor alpha by temozolomide in experimental glioblastoma.

Yamini B, Yu X, Gillespie GY, Kufe DW, Weichselbaum RR. Yamini B, et al. Among authors: weichselbaum rr. Cancer Res. 2004 Sep 15;64(18):6381-4. doi: 10.1158/0008-5472.CAN-04-2117. Cancer Res. 2004. PMID: 15374943

3

Ionizing radiation: a genetic switch for cancer therapy.

Mezhir JJ, Smith KD, Posner MC, Senzer N, Yamini B, Kufe DW, Weichselbaum RR. Mezhir JJ, et al. Among authors: weichselbaum rr. Cancer Gene Ther. 2006 Jan 1;13(1):1-6. doi: 10.1038/sj.cgt.7700879. Cancer Gene Ther. 2006. PMID: 16082378 Review.

4

Chemo-inducible gene therapy.

Mezhir JJ, Schmidt H, Yamini B, Senzer NN, Posner MC, Kufe DW, Weichselbaum RR. Mezhir JJ, et al. Among authors: weichselbaum rr. Anticancer Drugs. 2005 Nov;16(10):1053-8. doi: 10.1097/00001813-200511000-00003. Anticancer Drugs. 2005. PMID: 16222146 Review.

5

Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding.

Yamini B, Yu X, Dolan ME, Wu MH, Darga TE, Kufe DW, Weichselbaum RR. Yamini B, et al. Among authors: weichselbaum rr. Cancer Res. 2007 Jul 15;67(14):6889-98. doi: 10.1158/0008-5472.CAN-06-4496. Cancer Res. 2007. PMID: 17638900

6

Adenovirally delivered tumor necrosis factor-alpha improves the antiglioma efficacy of concomitant radiation and temozolomide therapy.

Yamini B, Yu X, Pytel P, Galanopoulos N, Rawlani V, Veerapong J, Bickenbach K, Weichselbaum RR. Yamini B, et al. Among authors: weichselbaum rr. Clin Cancer Res. 2007 Oct 15;13(20):6217-23. doi: 10.1158/1078-0432.CCR-07-1421. Clin Cancer Res. 2007. PMID: 17947489

7

p50 (NF-κB1) is an effector protein in the cytotoxic response to DNA methylation damage.

Schmitt AM, Crawley CD, Kang S, Raleigh DR, Yu X, Wahlstrom JS, Voce DJ, Darga TE, Weichselbaum RR, Yamini B. Schmitt AM, et al. Among authors: weichselbaum rr. Mol Cell. 2011 Dec 9;44(5):785-96. doi: 10.1016/j.molcel.2011.09.026. Mol Cell. 2011. PMID: 22152481 Free PMC article.

8

DNA damage-induced cytotoxicity is mediated by the cooperative interaction of phospho-NF-κB p50 and a single nucleotide in the κB-site.

Crawley CD, Raleigh DR, Kang S, Voce DJ, Schmitt AM, Weichselbaum RR, Yamini B. Crawley CD, et al. Among authors: weichselbaum rr. Nucleic Acids Res. 2013 Jan;41(2):764-74. doi: 10.1093/nar/gks1120. Epub 2012 Nov 24. Nucleic Acids Res. 2013. PMID: 23180782 Free PMC article.

9

Convection-enhanced delivery and in vivo imaging of polymeric nanoparticles for the treatment of malignant glioma.

Bernal GM, LaRiviere MJ, Mansour N, Pytel P, Cahill KE, Voce DJ, Kang S, Spretz R, Welp U, Noriega SE, Nunez L, Larsen GF, Weichselbaum RR, Yamini B. Bernal GM, et al. Among authors: weichselbaum rr. Nanomedicine. 2014 Jan;10(1):149-57. doi: 10.1016/j.nano.2013.07.003. Epub 2013 Jul 24. Nanomedicine. 2014. PMID: 23891990 Free PMC article.

10

Nfkb1 is a haploinsufficient DNA damage-specific tumor suppressor.

Voce DJ, Schmitt AM, Uppal A, McNerney ME, Bernal GM, Cahill KE, Wahlstrom JS, Nassiri A, Yu X, Crawley CD, White KP, Onel K, Weichselbaum RR, Yamini B. Voce DJ, et al. Among authors: weichselbaum rr. Oncogene. 2015 May 21;34(21):2807-13. doi: 10.1038/onc.2014.211. Epub 2014 Jul 21. Oncogene. 2015. PMID: 25043302 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

788 results

Search Page